[Morphofunctional status of the thymus in guinea pigs exposed to thymus and bone marrow preparations].
Khmel'nitskiĭ. O K OK; Grintsevich. I I II; Grigor'eva. Z G ZG; Morozov. V G VG; Khavinson. V Kh VKh
Key Findings
- Thymalin injection increased the count of small lymphocytes in the thymus.
- Hemalin injection increased the count of medium‑sized lymphocytes and lymphoblasts.
- Thymalin caused enlargement of the nuclei in reticuloendothelial cells of the thymus.
Practical Outcomes
- The study shows thymalin can shift immune cell populations in an animal model, hinting at possible immune‑modulating effects. However, because the work is limited to guinea pigs and lacks dosage or safety data for humans, it doesn’t provide a concrete protocol for biohackers. It may be of interest for those tracking emerging immune‑support compounds, but more human research is needed before practical use.
Summary
In a guinea‑pig study, giving the peptide thymalin boosted the number of small immune cells in the thymus, while a related peptide called hemalin raised medium‑sized immune cells and early‑stage cells. Thymalin also made certain thymus cells' nuclei bigger.
Abstract
Study of the effect of the polypeptide thymic factor (thymalin) and the polypeptide bone marrow factor (hemalin) on the morphofunctional status of the thymus in guinea-pigs has shown that injection of thymalin into animals increases the count of small lymphocytes whereas injection of hemalin the count of medium-sized lymphocytes and lymphoblasts. Injection of thymalin magnifies the size of the nuclei of the reticuloendothelial cells.
Study Information
pubmed
1985